Nifty
:
19523.55
Sensex
:
65508.32
-192.90 (-0.98%)
-610.37 (-0.92%)
Nifty
Sensex
:
:
19523.55
65508.32
-192.90 (-0.98%)
-610.37 (-0.92%)

Themis Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
64/99

BSE: 530199 | NSE: THEMISMED

NSE BSE
1763.05
28-Sep-2023
  • Open
  • High
  • Low
  • Previous Close
  •  1756.90
  •  1770.00
  •  1702.35
  •  1735.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9071
  •  158.24
  •  1801.85
  •  877.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,599.40
  • 27.68
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,672.47
  • 0.29%
  • 4.54

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.16%
  • 4.88%
  • 22.64%
  • FII
  • DII
  • Others
  • 0.04%
  • 0.00%
  • 5.28%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.15
  • 14.03
  • 15.38

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.86
  • 97.06
  • 6.39

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.64
  • -
  • 29.45

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.32
  • 14.49
  • 14.11

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.11
  • 2.60
  • 3.17

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.56
  • 19.70
  • 12.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Net Sales
96.65
94.44
2.34%
80.10
79.80
0.38%
88.78
94.92
-6.47%
91.00
107.39
-15.26%
Expenses
74.91
74.08
1.12%
69.63
65.39
6.48%
73.51
77.63
-5.31%
69.66
83.93
-17.00%
EBITDA
21.74
20.36
6.78%
10.48
14.41
-27.27%
15.27
17.29
-11.68%
21.34
23.46
-9.04%
EBIDTM
22.50%
21.56%
13.08%
18.06%
17.20%
18.22%
23.45%
21.85%
Other Income
0.65
0.69
-5.80%
2.95
1.84
60.33%
5.90
4.14
42.51%
1.97
0.21
838.10%
Interest
2.49
2.26
10.18%
2.71
1.93
40.41%
2.23
2.13
4.69%
2.37
2.05
15.61%
Depreciation
3.02
2.46
22.76%
2.80
2.39
17.15%
2.67
2.36
13.14%
2.56
2.38
7.56%
PBT
16.88
16.33
3.37%
7.92
11.93
-33.61%
16.27
16.94
-3.96%
18.38
19.25
-4.52%
Tax
4.32
4.69
-7.89%
1.89
4.39
-56.95%
4.19
4.79
-12.53%
4.85
4.13
17.43%
PAT
12.55
11.63
7.91%
6.04
7.54
-19.89%
12.08
12.15
-0.58%
13.53
15.12
-10.52%
PATM
12.99%
12.32%
7.54%
9.45%
13.61%
12.80%
14.87%
14.08%
EPS
19.77
18.92
4.49%
9.13
10.82
-15.62%
14.47
13.54
6.87%
19.33
20.95
-7.73%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
356.53
354.32
394.61
230.67
201.59
183.75
209.50
216.66
232.43
201.88
195.07
Net Sales Growth
-5.32%
-10.21%
71.07%
14.43%
9.71%
-12.29%
-3.30%
-6.78%
15.13%
3.49%
 
Cost Of Goods Sold
117.82
100.52
131.00
67.35
51.97
58.82
57.75
55.66
71.38
79.51
76.68
Gross Profit
238.71
253.81
263.62
163.33
149.62
124.94
151.75
160.99
161.06
122.37
118.39
GP Margin
66.95%
71.63%
66.81%
70.81%
74.22%
67.99%
72.43%
74.31%
69.29%
60.62%
60.69%
Total Expenditure
287.71
286.87
298.98
181.18
165.93
181.48
184.98
184.29
194.28
183.91
171.01
Power & Fuel Cost
-
11.83
12.18
11.32
11.49
9.70
8.41
9.77
10.83
8.36
10.04
% Of Sales
-
3.34%
3.09%
4.91%
5.70%
5.28%
4.01%
4.51%
4.66%
4.14%
5.15%
Employee Cost
-
66.15
51.97
39.99
44.28
45.69
44.65
40.00
36.30
32.64
31.14
% Of Sales
-
18.67%
13.17%
17.34%
21.97%
24.87%
21.31%
18.46%
15.62%
16.17%
15.96%
Manufacturing Exp.
-
36.95
40.23
21.41
24.01
22.45
27.46
31.30
31.28
21.69
16.38
% Of Sales
-
10.43%
10.19%
9.28%
11.91%
12.22%
13.11%
14.45%
13.46%
10.74%
8.40%
General & Admin Exp.
-
24.29
18.66
12.03
14.05
17.57
18.93
18.86
14.75
13.52
11.72
% Of Sales
-
6.86%
4.73%
5.22%
6.97%
9.56%
9.04%
8.70%
6.35%
6.70%
6.01%
Selling & Distn. Exp.
-
26.74
26.08
14.92
12.28
17.71
18.27
16.70
12.05
10.87
10.06
% Of Sales
-
7.55%
6.61%
6.47%
6.09%
9.64%
8.72%
7.71%
5.18%
5.38%
5.16%
Miscellaneous Exp.
-
20.40
18.86
14.16
7.86
9.54
9.51
11.99
17.69
17.32
10.06
% Of Sales
-
5.76%
4.78%
6.14%
3.90%
5.19%
4.54%
5.53%
7.61%
8.58%
7.68%
EBITDA
68.83
67.45
95.63
49.49
35.66
2.27
24.52
32.37
38.15
17.97
24.06
EBITDA Margin
19.31%
19.04%
24.23%
21.45%
17.69%
1.24%
11.70%
14.94%
16.41%
8.90%
12.33%
Other Income
11.47
11.50
6.54
3.62
3.46
2.67
3.49
3.32
3.19
12.59
4.90
Interest
9.80
9.56
8.77
12.71
12.88
11.82
11.87
11.84
12.33
14.53
15.63
Depreciation
11.05
10.49
9.48
8.55
8.27
7.99
7.42
7.47
11.89
11.49
9.36
PBT
59.45
58.90
83.92
31.86
17.97
-14.87
8.74
16.37
17.13
4.54
3.98
Tax
15.25
15.61
22.38
5.63
2.09
-1.84
0.10
1.60
1.91
-0.89
1.28
Tax Rate
25.65%
26.50%
26.67%
17.67%
11.63%
12.37%
1.14%
9.77%
11.15%
-19.60%
32.16%
PAT
44.20
56.90
72.88
26.23
15.88
-13.01
8.70
14.77
15.22
5.44
2.70
PAT before Minority Interest
44.20
56.90
72.88
26.23
15.88
-13.03
8.64
14.77
15.22
5.44
2.70
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.02
0.06
0.00
0.00
0.00
0.00
PAT Margin
12.40%
16.06%
18.47%
11.37%
7.88%
-7.08%
4.15%
6.82%
6.55%
2.69%
1.38%
PAT Growth
-4.82%
-21.93%
177.85%
65.18%
-
-
-41.10%
-2.96%
179.78%
101.48%
 
EPS
48.04
61.85
79.22
28.51
17.26
-14.14
9.46
16.05
16.54
5.91
2.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
339.44
287.49
218.51
183.02
158.09
168.91
152.44
74.03
59.20
56.53
Share Capital
9.20
9.20
9.19
9.19
9.18
9.18
9.04
8.52
8.47
8.45
Total Reserves
330.17
278.05
208.95
173.35
148.31
159.18
141.36
65.51
50.73
48.08
Non-Current Liabilities
35.39
30.77
24.33
7.51
2.71
6.72
7.60
70.83
82.04
89.97
Secured Loans
18.62
10.91
5.73
0.09
0.14
0.01
0.47
15.89
18.83
24.47
Unsecured Loans
9.83
12.97
16.47
11.76
9.21
11.48
11.93
47.52
55.81
52.30
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.54
0.49
0.46
Current Liabilities
149.38
123.52
128.31
154.81
146.69
124.94
124.17
129.66
135.61
137.09
Trade Payables
40.04
31.87
30.79
29.68
35.04
30.55
31.63
34.90
60.15
56.97
Other Current Liabilities
40.28
29.93
39.09
46.86
43.72
29.76
38.13
37.04
16.51
23.68
Short Term Borrowings
48.91
43.10
56.93
76.61
66.86
63.73
53.45
51.88
53.78
52.74
Short Term Provisions
20.14
18.61
1.49
1.66
1.07
0.90
0.95
5.83
5.17
3.71
Total Liabilities
524.21
441.78
371.15
345.34
307.47
300.51
284.21
274.52
276.85
283.59
Net Block
162.20
144.00
133.10
116.31
123.41
125.90
123.71
117.35
122.32
121.26
Gross Block
221.02
192.36
172.24
147.14
146.06
140.78
131.17
212.16
206.19
192.01
Accumulated Depreciation
58.82
48.36
39.14
30.83
22.66
14.87
7.46
94.80
83.87
70.75
Non Current Assets
249.43
213.62
185.67
164.85
157.61
157.47
159.81
141.68
143.38
149.17
Capital Work in Progress
2.60
2.56
2.47
7.54
2.45
2.47
8.95
5.79
3.50
11.63
Non Current Investment
70.00
56.31
44.96
35.47
26.64
24.38
21.83
5.64
4.59
3.59
Long Term Loans & Adv.
12.81
6.90
2.83
2.91
2.67
2.39
3.01
12.19
12.70
12.11
Other Non Current Assets
1.82
3.84
2.31
2.62
2.45
2.33
2.30
0.70
0.28
0.58
Current Assets
274.78
228.16
185.47
180.49
149.86
143.04
124.40
132.83
133.47
134.44
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
1.05
0.00
0.00
0.00
Inventories
68.95
60.81
58.49
54.61
53.63
49.58
48.44
58.26
62.30
66.34
Sundry Debtors
145.02
100.56
77.61
102.48
72.91
68.63
48.25
47.57
45.56
39.58
Cash & Bank
18.89
26.50
24.63
5.29
3.45
6.91
8.62
14.30
8.70
6.57
Other Current Assets
41.91
5.94
5.89
5.83
19.87
17.91
18.04
12.70
16.92
21.94
Short Term Loans & Adv.
35.24
34.34
18.84
12.28
14.45
12.57
12.72
11.34
15.58
20.57
Net Current Assets
125.40
104.64
57.16
25.68
3.18
18.09
0.23
3.18
-2.14
-2.66
Total Assets
524.21
441.78
371.14
345.34
307.47
300.51
284.21
274.51
276.85
283.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
16.09
34.39
56.98
0.33
10.92
7.86
-1.51
25.76
19.09
8.35
PBT
72.51
95.26
41.33
26.87
-12.60
11.33
17.56
30.52
19.85
19.61
Adjustment
0.03
-0.24
7.66
9.33
16.74
14.93
15.92
10.05
10.48
8.47
Changes in Working Capital
-40.30
-42.55
7.90
-35.63
7.08
-19.05
-35.16
-0.57
2.40
-2.82
Cash after chg. in Working capital
32.25
52.47
56.90
0.57
11.22
7.21
-1.67
40.00
32.73
25.26
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-12.33
-14.53
0.00
Tax Paid
-16.15
-18.07
0.08
-0.24
-0.30
0.65
0.16
-1.91
0.89
-1.28
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-23.96
-15.59
-15.65
-5.47
-3.72
-0.04
-4.14
-7.17
-6.27
-6.71
Net Fixed Assets
-28.70
-20.21
-20.03
-6.16
-5.34
-3.11
20.82
-6.64
-2.13
-3.68
Net Investments
-0.05
-0.03
-0.02
0.06
-0.01
1.01
-1.33
0.01
-0.23
0.00
Others
4.79
4.65
4.40
0.63
1.63
2.06
-23.63
-0.54
-3.91
-3.03
Cash from Financing Activity
0.14
-17.55
-25.65
6.72
-9.94
-9.11
5.27
-13.29
-17.96
1.89
Net Cash Inflow / Outflow
-7.73
1.26
15.68
1.59
-2.74
-1.29
-0.38
5.31
-5.14
3.52
Opening Cash & Equivalents
20.28
19.02
3.34
1.75
4.49
5.78
6.16
-39.67
-34.53
-38.05
Closing Cash & Equivalent
12.55
20.28
19.02
3.34
1.75
4.49
5.78
-34.36
-39.67
-34.53

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
368.78
312.22
237.41
198.67
171.54
183.39
166.38
86.94
69.91
66.90
ROA
11.78%
17.93%
7.32%
4.86%
-4.29%
2.95%
5.29%
5.52%
1.94%
0.97%
ROE
18.16%
28.84%
13.09%
9.34%
-8.00%
5.42%
13.16%
22.85%
9.40%
5.00%
ROCE
20.59%
31.07%
15.21%
11.81%
-1.25%
8.52%
12.92%
14.69%
9.45%
9.53%
Fixed Asset Turnover
1.71
2.16
1.44
1.38
1.28
1.56
1.32
1.13
1.03
1.04
Receivable days
126.49
82.40
142.49
158.78
140.57
100.75
77.33
72.04
76.05
66.90
Inventory Days
66.84
55.18
89.48
97.99
102.51
84.49
86.11
93.26
114.91
112.58
Payable days
130.58
87.30
163.89
75.58
71.78
69.42
73.88
99.57
126.74
123.69
Cash Conversion Cycle
62.75
50.27
68.08
181.20
171.29
115.83
89.56
65.73
64.22
55.79
Total Debt/Equity
0.27
0.27
0.39
0.54
0.52
0.48
0.55
1.73
2.37
2.61
Interest Cover
8.58
11.86
3.51
2.40
-0.26
1.74
2.38
2.39
1.31
1.25

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Themis Medicare incorporates wholly owned subsidiary
    20th Sep 2023, 14:22 PM

    The company has incorporated wholly owned subsidiary of the Company in the name of ‘Rx Themis’ on September 19, 2023

    Read More
  • Themis Medicare - Quarterly Results
    10th Aug 2023, 15:18 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.